NFKB1 and breast cancer: PN was identified in leukemia and in solid tumors as the first small molecule capable of killing CSCs.38 Recently, Zhou et al.24 showed that PN inhibited the production of mammospheres from breast cancer MCF-7 cells, an effect that was caused by inhibition of NF-κB activity.